Amsterdam-based fintech Blanco raises €3M; appoints new co-CEO
Blanco WealthTech, an Amsterdam-based fintech that develops technology for wealth managers, announced that it has secured over €3M from…
Breaking news and analysis from technology, capital, and policy — the moves that matter for the people building, funding, and regulating the technology economy.
13,172 articles · News
Blanco WealthTech, an Amsterdam-based fintech that develops technology for wealth managers, announced that it has secured over €3M from…
Swissquote with its technology platform and Keytrade Bank Luxembourg with its ‘strong’ domestic presence aim to become the leader of digital investing services in Luxembourg through this acquisition.
Here are a few fintech startups in the Benelux region that have raised funding this year as sourced from Dealroom.
Good Loop is an ad tech platform that drives ad engagement by converting people’s attention into donations to good causes around the world.
Depict.ai, a Stockholm-based AI platform that provides product recommendations to e-commerce stores without needing any transaction data, announced that it has secured $17M (approx €15.2M) in a Series A round of funding led by Tiger Global.
The Ukrainian tech community is showing signs of resilience as Russia invades the country and big tech giants battle the tension caused by propaganda.
Eindhoven headquartered AI-based edtech startup chunkx announced that it has secured Seed funding from LUMO Labs, through the LUMO Fund II.…
Cybersprint is an attack surface management company that provides continuous, real-time insights from an outside-in perspective to eliminate blind spots and detect risks.
In today’s world, gaining a competitive edge is vital for any student to have a successful career.
Gousto was founded in 2012 to pioneer the recipe box offering in the UK.
Speech Graphics delivers facial animation technology to the entertainment industry, working with clients such as Warner Brothers and Def Jam Recordings.
TargED Biopharmaceuticals, an Utrecht-based biotechnology company focused on developing improved treatments for thrombotic diseases, announced that it has secured €39M in a Series A round of funding.